{"title":"补充精氨酸对危重症患儿利尿效果的影响。","authors":"Matthew Ballweg, Laura A Ortmann","doi":"10.5863/1551-6776-30.1.93","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Hypochloremia is common in children receiving diuretics and may contribute to diuretic -resistance. This study's objective was to investigate whether arginine hydrochloride supplementation for -hypochloremia was associated with a change in urine output (UOP) or fluid balance (FB) in children -receiving diuretics.</p><p><strong>Methods: </strong>This was an observational retrospective study of children admitted to the pediatric, cardiac, or neonatal intensive care unit. Patients were included if they received at least 3 days of loop or thiazide diuretics then supplemented with arginine hydrochloride during ongoing diuresis. Data collected included diagnosis category, electrolyte supplementation and serum concentrations, weights, and all fluid input and output. UOP and FB were compared in the 48 hours before and after supplementation.</p><p><strong>Results: </strong>Of the 345 children studied, 60% had underlying cardiac disease and 97% received furosemide. Median arginine hydrochloride dose was 0.9 mEq/kg, most often given every 6 hours for 4 doses. Serum chloride concentrations rose from 91.6 to 96.4 mmol/L (p < 0.001). There was no difference in UOP (4.6 vs 4.4 mL/kg/hr, p = 0.06) or FB (1.5 vs 2.7 mL/kg/day, p = 0.13) when comparing the 48 hours before supplementation with the 48 hours after. Analyses of patients with stable diuretic dosing, those with a serum chloride concentration ≤90 mmol/L, those with an increase in serum chloride ≥8 mmol/L, and those with cardiac disease had no improvement in UOP or FB after chloride supplementation.</p><p><strong>Conclusions: </strong>Arginine hydrochloride supplementation was not associated with an improvement in diuretic effectiveness in children as demonstrated by lack of improvement in UOP or FB.</p>","PeriodicalId":37484,"journal":{"name":"Journal of Pediatric Pharmacology and Therapeutics","volume":"30 1","pages":"93-99"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11809545/pdf/","citationCount":"0","resultStr":"{\"title\":\"Impact of Arginine Hydrochloride Supplementation on Diuretic Effectiveness in Critically Ill Children.\",\"authors\":\"Matthew Ballweg, Laura A Ortmann\",\"doi\":\"10.5863/1551-6776-30.1.93\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Hypochloremia is common in children receiving diuretics and may contribute to diuretic -resistance. This study's objective was to investigate whether arginine hydrochloride supplementation for -hypochloremia was associated with a change in urine output (UOP) or fluid balance (FB) in children -receiving diuretics.</p><p><strong>Methods: </strong>This was an observational retrospective study of children admitted to the pediatric, cardiac, or neonatal intensive care unit. Patients were included if they received at least 3 days of loop or thiazide diuretics then supplemented with arginine hydrochloride during ongoing diuresis. Data collected included diagnosis category, electrolyte supplementation and serum concentrations, weights, and all fluid input and output. UOP and FB were compared in the 48 hours before and after supplementation.</p><p><strong>Results: </strong>Of the 345 children studied, 60% had underlying cardiac disease and 97% received furosemide. Median arginine hydrochloride dose was 0.9 mEq/kg, most often given every 6 hours for 4 doses. Serum chloride concentrations rose from 91.6 to 96.4 mmol/L (p < 0.001). There was no difference in UOP (4.6 vs 4.4 mL/kg/hr, p = 0.06) or FB (1.5 vs 2.7 mL/kg/day, p = 0.13) when comparing the 48 hours before supplementation with the 48 hours after. Analyses of patients with stable diuretic dosing, those with a serum chloride concentration ≤90 mmol/L, those with an increase in serum chloride ≥8 mmol/L, and those with cardiac disease had no improvement in UOP or FB after chloride supplementation.</p><p><strong>Conclusions: </strong>Arginine hydrochloride supplementation was not associated with an improvement in diuretic effectiveness in children as demonstrated by lack of improvement in UOP or FB.</p>\",\"PeriodicalId\":37484,\"journal\":{\"name\":\"Journal of Pediatric Pharmacology and Therapeutics\",\"volume\":\"30 1\",\"pages\":\"93-99\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11809545/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pediatric Pharmacology and Therapeutics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5863/1551-6776-30.1.93\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/10 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pediatric Pharmacology and Therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5863/1551-6776-30.1.93","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/10 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
目的:低氯血症常见于接受利尿剂治疗的儿童,并可能导致利尿剂抵抗。本研究的目的是调查在接受利尿剂的儿童中,补充盐酸精氨酸是否与尿量(UOP)或体液平衡(FB)的改变有关。方法:这是一项观察性回顾性研究,研究对象是儿科、心脏或新生儿重症监护病房的儿童。如果患者接受了至少3天的环类或噻嗪类利尿剂,然后在持续利尿期间补充盐酸精氨酸,则纳入研究。收集的数据包括诊断类别、电解质补充和血清浓度、体重和所有液体输入和输出。比较补充前后48小时的UOP和FB。结果:在研究的345名儿童中,60%患有潜在心脏病,97%接受了速尿治疗。盐酸精氨酸的中位剂量为0.9 mEq/kg,通常每6小时给药一次,共给药4次。血清氯离子浓度由91.6 mmol/L升高至96.4 mmol/L (p < 0.001)。在补充前48小时与补充后48小时比较,UOP (4.6 vs 4.4 mL/kg/hr, p = 0.06)或FB (1.5 vs 2.7 mL/kg/day, p = 0.13)没有差异。对利尿剂剂量稳定、血清氯化物浓度≤90 mmol/L、血清氯化物升高≥8 mmol/L以及患有心脏病的患者进行分析,在补充氯化物后UOP或FB均无改善。结论:在UOP或FB缺乏改善的情况下,补充精氨酸盐酸盐与儿童利尿效果的改善无关。
Impact of Arginine Hydrochloride Supplementation on Diuretic Effectiveness in Critically Ill Children.
Objective: Hypochloremia is common in children receiving diuretics and may contribute to diuretic -resistance. This study's objective was to investigate whether arginine hydrochloride supplementation for -hypochloremia was associated with a change in urine output (UOP) or fluid balance (FB) in children -receiving diuretics.
Methods: This was an observational retrospective study of children admitted to the pediatric, cardiac, or neonatal intensive care unit. Patients were included if they received at least 3 days of loop or thiazide diuretics then supplemented with arginine hydrochloride during ongoing diuresis. Data collected included diagnosis category, electrolyte supplementation and serum concentrations, weights, and all fluid input and output. UOP and FB were compared in the 48 hours before and after supplementation.
Results: Of the 345 children studied, 60% had underlying cardiac disease and 97% received furosemide. Median arginine hydrochloride dose was 0.9 mEq/kg, most often given every 6 hours for 4 doses. Serum chloride concentrations rose from 91.6 to 96.4 mmol/L (p < 0.001). There was no difference in UOP (4.6 vs 4.4 mL/kg/hr, p = 0.06) or FB (1.5 vs 2.7 mL/kg/day, p = 0.13) when comparing the 48 hours before supplementation with the 48 hours after. Analyses of patients with stable diuretic dosing, those with a serum chloride concentration ≤90 mmol/L, those with an increase in serum chloride ≥8 mmol/L, and those with cardiac disease had no improvement in UOP or FB after chloride supplementation.
Conclusions: Arginine hydrochloride supplementation was not associated with an improvement in diuretic effectiveness in children as demonstrated by lack of improvement in UOP or FB.
期刊介绍:
The Journal of Pediatric Pharmacology and Therapeutics is the official journal of the Pediatric Pharmacy Advocacy Group. JPPT is a peer-reviewed multi disciplinary journal that is devoted to promoting the safe and effective use of medications in infants and children. To this end, the journal publishes practical information for all practitioners who provide care to pediatric patients. Each issue includes review articles, original clinical investigations, case reports, editorials, and other information relevant to pediatric medication therapy. The Journal focuses all work on issues related to the practice of pediatric pharmacology and therapeutics. The scope of content includes pharmacotherapy, extemporaneous compounding, dosing, methods of medication administration, medication error prevention, and legislative issues. The Journal will contain original research, review articles, short subjects, case reports, clinical investigations, editorials, and news from such organizations as the Pediatric Pharmacy Advocacy Group, the FDA, the American Academy of Pediatrics, the American Society of Health-System Pharmacists, and so on.